Literature DB >> 10559324

Induction of transformation and p53-dependent apoptosis by adenovirus type 5 E4orf6/7 cDNA.

S Yamano1, T Tokino, M Yasuda, M Kaneuchi, M Takahashi, Y Niitsu, K Fujinaga, T Yamashita.   

Abstract

Adenovirus (Ad) E4orf6/7, one of the early gene products of human Ads, forms a stable complex with the cellular transcription factor E2F to activate transcription from the Ad E2 promoter. E2F cDNAs have growth-promoting and apoptosis-inducing activities when overexpressed in cells. We cloned Ad5 E4orf6/7 cDNA in both simian virus 40- and human cytomegalovirus-based expression vectors to examine its transforming and apoptotic activities. The cloned E4orf6/7 collaborated with a retinoblastoma protein (RB)-nonbinding and therefore E2F-nonreleasing mutant of Ad5 E1A (dl922/947) to morphologically transform primary rat cells, suggesting that E2F is an important cellular protein functioning downstream of E1A for transformation. In a G418 colony formation assay, E4orf6/7 was shown to suppress growth of untransformed rat cells. Moreover, a recombinant Ad expressing Ad5 E4orf6/7 induced apoptosis in rat cells when coinfected with wild-type p53-expressing Ad. Mutational analysis of E4orf6/7 revealed that both of the domains required for growth inhibition and transformation by E4orf6/7 lay in the C-terminal region, which is essential for transactivation from the upstream sequence of an E2a promoter containing E2F-binding sites. However, the smallest mutant of E4orf6/7, encoding the C-terminal 59 amino acids, failed to complement the RB-nonbinding dl922/947 mutant despite showing growth inhibition and E2F transactivation activities. Thus, it is suggested that a subregion of E4orf6/7 which is required for growth inhibition and transformation in collaboration with dl922/947 overlaps the transactivation domain of E4orf6/7.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559324      PMCID: PMC113061     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

Authors:  L Rao; M Debbas; P Sabbatini; D Hockenbery; S Korsmeyer; E White
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

3.  The C-terminal 70 amino acids of the adenovirus E4-ORF6/7 protein are essential and sufficient for E2F complex formation.

Authors:  R J O'Connor; P Hearing
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

4.  Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

Authors:  M Debbas; E White
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

5.  Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.

Authors:  P R Yew; A J Berk
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

6.  Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.

Authors:  S W Lowe; H E Ruley
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

7.  Requirement for the adenovirus type 9 E4 region in production of mammary tumors.

Authors:  R Javier; K Raska; T Shenk
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

8.  The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein.

Authors:  J Han; P Sabbatini; D Perez; L Rao; D Modha; E White
Journal:  Genes Dev       Date:  1996-02-15       Impact factor: 11.361

9.  The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha.

Authors:  E White; P Sabbatini; M Debbas; W S Wold; D I Kusher; L R Gooding
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

10.  Tumorigenic transformation of primary rat embryonal fibroblasts by human papillomavirus type 8 E7 gene in collaboration with the activated H-ras gene.

Authors:  T Nishikawa; T Yamashita; T Yamada; H Kobayashi; A Ohkawara; K Fujinaga
Journal:  Jpn J Cancer Res       Date:  1991-12
View more
  8 in total

1.  Several E4 region functions influence mammary tumorigenesis by human adenovirus type 9.

Authors:  D L Thomas; J Schaack; H Vogel; R Javier
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  "Hit-and-run" transformation by adenovirus oncogenes.

Authors:  M Nevels; B Täuber; T Spruss; H Wolf; T Dobner
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein.

Authors:  M Nevels; S Rubenwolf; T Spruss; H Wolf; T Dobner
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Full genome sequence analysis of a novel adenovirus of rhesus macaque origin indicates a new simian adenovirus type and species.

Authors:  Daniel Malouli; Grant L Howell; Alfred W Legasse; Christoph Kahl; Michael K Axthelm; Scott G Hansen; Klaus Früh
Journal:  Virol Rep       Date:  2014-09

5.  Potential involvement of p53 in ischemia/reperfusion-induced osteonecrosis.

Authors:  Chiaki Okuma; Takefumi Kaketa; Atsuhiko Hikita; Koichi Matsuda; Masaki Nakamura; Yuichi Nagase; Yasushi Oshima; Mitsuyasu Iwasawa; Yusuke Nakamura; Hisashi Kurosawa; Kozo Nakamura; Sakae Tanaka
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

Review 6.  Cell polarity proteins: common targets for tumorigenic human viruses.

Authors:  R T Javier
Journal:  Oncogene       Date:  2008-11-24       Impact factor: 9.867

Review 7.  NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses-Therapeutic Perspectives.

Authors:  Justyna Struzik; Lidia Szulc-Dąbrowska
Journal:  Cancers (Basel)       Date:  2018-11-08       Impact factor: 6.639

8.  Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein.

Authors:  Sandra Blanco; Marta Sanz-García; Claudio R Santos; Pedro A Lazo
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.